New strategies and patent therapeutics in EBV-associated diseases.
Villegas
E
E
Department of Microbiology, School of Medicine, University of Granada, Spain.
Santiago
O
O
Sorlózano
A
A
Gutierrez
J
J
D000998:Antiviral Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000821:virology; D018984:Epitopes, T-Lymphocyte / Q000276:immunology; D020031:Epstein-Barr Virus Infections / Q000517:prevention & control / Q000628:therapy* / Q000821:virology; D015316:Genetic Therapy; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000254:growth & development / Q000472:pathogenicity*; D006801:Humans; D009369:Neoplasms / Q000821:virology; D010330:Patents as Topic; D022223:Vaccines, Subunit / Q000276:immunology
D000998:Antiviral Agents; D018984:Epitopes, T-Lymphocyte; D022223:Vaccines, Subunit